These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 16645011)
21. Changes in expression of T-helper (Th) 1- and Th2-associated chemokine receptors on peripheral blood lymphocytes and plasma concentrations of their ligands, interferon-inducible protein-10 and thymus and activation-regulated chemokine, after antithyroid drug administration in hyperthyroid patients with Graves' disease. Inukai Y; Momobayashi A; Sugawara N; Aso Y Eur J Endocrinol; 2007 Jun; 156(6):623-30. PubMed ID: 17535861 [TBL] [Abstract][Full Text] [Related]
22. Increased serum neopterin levels in patients with Graves' disease. Wagner R; Hayatghebi S; Rosenkranz M; Reinwein D Exp Clin Endocrinol; 1993; 101(4):249-54. PubMed ID: 8307114 [TBL] [Abstract][Full Text] [Related]
23. Toxic multinodular goiter: a variant of autoimmune hyperthyroidism. Kraiem Z; Glaser B; Yigla M; Pauker J; Sadeh O; Sheinfeld M J Clin Endocrinol Metab; 1987 Oct; 65(4):659-64. PubMed ID: 2888784 [TBL] [Abstract][Full Text] [Related]
24. Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. Effraimidis G; Strieder TG; Tijssen JG; Wiersinga WM Eur J Endocrinol; 2011 Jan; 164(1):107-13. PubMed ID: 20956436 [TBL] [Abstract][Full Text] [Related]
26. Persistent remission of Graves` disease or evolution from Graves' disease to Hashimoto's thyroiditis in childhood - a report of 6 cases and clinical implications. Smyczńyska J; Cyniak-Magierska A; Stasiak M; Karbownik-Lewińska M; Lewiński A Neuro Endocrinol Lett; 2014; 35(5):335-41. PubMed ID: 25275265 [TBL] [Abstract][Full Text] [Related]
27. High levels of serum soluble interleukin-2 receptors in hyperthyroid patients: correlation with serum thyroid hormones and independence from the etiology of the hyperthyroidism. Koukkou E; Panayiotidis P; Alevizou-Terzaki V; Thalassinos N J Clin Endocrinol Metab; 1991 Oct; 73(4):771-6. PubMed ID: 1909702 [TBL] [Abstract][Full Text] [Related]
28. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease. Roti E; Minelli R; Gardini E; Bianconi L; Salvi M; Gavaruzzi G; Ugolotti G; Braverman LE J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159 [TBL] [Abstract][Full Text] [Related]
29. [Analysis of serum levels of ghrelin and obestatin in children and adolescents with autoimmune thyroid diseases]. Sawicka B; Bossowski A; Urban M; Szalecki M; Wysocka J; Koput A; Zelazowska-Rutkowska B; Tobolczyk J; Skrzydło M; Rogowski F; Luba M Pediatr Endocrinol Diabetes Metab; 2009; 15(1):20-7. PubMed ID: 19454185 [TBL] [Abstract][Full Text] [Related]
30. Thyroxine may decrease serum thyroxine-binding globulin levels. Lin JY; Hwu-Liaw SE; Chang TC Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):342-5. PubMed ID: 2507733 [TBL] [Abstract][Full Text] [Related]
31. Influence of methimazole and radioactive iodine treatment in the serum levels of the chemokine CXCL10 in hyperthyroid patients with Graves' disease. Leite AC; Pedro AB; Romaldini JH Horm Metab Res; 2011 Mar; 43(3):194-9. PubMed ID: 21283953 [TBL] [Abstract][Full Text] [Related]
32. [Goiter]. Bürgi U; Studer H Schweiz Med Wochenschr; 1986 Mar; 116(11):326-31. PubMed ID: 3754351 [TBL] [Abstract][Full Text] [Related]
34. Simultaneous measurement of serum chemokines in autoimmune thyroid diseases: possible role of IP-10 in the inflammatory response. Hiratsuka I; Itoh M; Yamada H; Yamamoto K; Tomatsu E; Makino M; Hashimoto S; Suzuki A Endocr J; 2015; 62(12):1059-66. PubMed ID: 26400025 [TBL] [Abstract][Full Text] [Related]
35. [Impact of serum thyroglobulin concentration in the diagnosis of benign and malignant thyroid diseases]. Rink T; Dembowski W; Schroth HJ; Klinger K Nuklearmedizin; 2000 Aug; 39(5):133-8. PubMed ID: 10984889 [TBL] [Abstract][Full Text] [Related]
36. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry. Chan JY; Walfish PG J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483 [TBL] [Abstract][Full Text] [Related]
37. Determination of replacement and suppressive doses of thyroxine. Banovac K; Carrington SA; Levis S; Fill MD; Bilsker MS J Int Med Res; 1990; 18(3):210-8. PubMed ID: 2361563 [TBL] [Abstract][Full Text] [Related]